TY - JOUR
T1 - A Retrospective Cohort Study of Cutaneous Squamous Cell Carcinoma with Lymph Node Metastasis
T2 - Risk Factors and Clinical Course
AU - Feinstein, Shera
AU - Higgins, Shauna
AU - Ahadiat, Omeed
AU - Wysong, Ashley
PY - 2019/6/1
Y1 - 2019/6/1
N2 - BACKGROUNDThe single most important prognostic indicator for mortality in patients with cutaneous squamous cell carcinoma (SCC) is the development of nodal metastasis (NM).OBJECTIVETo characterize the risk factors for and clinical course of cutaneous SCC with NM.METHODSTen-year retrospective cohort study (2006-2017) at an academic tertiary care center reviewing 53 cutaneous SCC tumors with NM.RESULTSMost patients were men (84.6%, 44/52), and almost all primary tumors were on the head and neck (96.2%, 51/53). Most primary tumors were characterized by known "high-risk features" including perineural invasion (56.6%, 30/53), diameter ≥2 cm (54.7%, 29/53), invasion beyond subcutaneous fat (43.4%, 23/53), and poor differentiation (32.1%, 17/53). In addition, many tumors were recurrent (52.8%, 28/53), and many patients were immunosuppressed (30.8%, 16/52). Disease-free survival after treatment of nodal disease was 7.5% (4/53) at 5 years.CONCLUSIONTo the best of the authors' knowledge, this study is the largest retrospective cohort of cutaneous SCC with NM to date. The results verify the significance of "high-risk features" used by current staging systems while highlighting additional features that may have prognostic value. This study may be used to refine current staging systems, improve early detection, and optimize management for these aggressive tumors.
AB - BACKGROUNDThe single most important prognostic indicator for mortality in patients with cutaneous squamous cell carcinoma (SCC) is the development of nodal metastasis (NM).OBJECTIVETo characterize the risk factors for and clinical course of cutaneous SCC with NM.METHODSTen-year retrospective cohort study (2006-2017) at an academic tertiary care center reviewing 53 cutaneous SCC tumors with NM.RESULTSMost patients were men (84.6%, 44/52), and almost all primary tumors were on the head and neck (96.2%, 51/53). Most primary tumors were characterized by known "high-risk features" including perineural invasion (56.6%, 30/53), diameter ≥2 cm (54.7%, 29/53), invasion beyond subcutaneous fat (43.4%, 23/53), and poor differentiation (32.1%, 17/53). In addition, many tumors were recurrent (52.8%, 28/53), and many patients were immunosuppressed (30.8%, 16/52). Disease-free survival after treatment of nodal disease was 7.5% (4/53) at 5 years.CONCLUSIONTo the best of the authors' knowledge, this study is the largest retrospective cohort of cutaneous SCC with NM to date. The results verify the significance of "high-risk features" used by current staging systems while highlighting additional features that may have prognostic value. This study may be used to refine current staging systems, improve early detection, and optimize management for these aggressive tumors.
UR - http://www.scopus.com/inward/record.url?scp=85066928449&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066928449&partnerID=8YFLogxK
U2 - 10.1097/DSS.0000000000001828
DO - 10.1097/DSS.0000000000001828
M3 - Article
C2 - 30789511
AN - SCOPUS:85066928449
SN - 1076-0512
VL - 45
SP - 772
EP - 781
JO - Journal of Dermatologic Surgery and Oncology
JF - Journal of Dermatologic Surgery and Oncology
IS - 6
ER -